Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Miller

Showing results (521-530 of 655) with videos related to

Pageof 66
Sort By:
JACC. Advances|February 10, 2026
A Clinician's Guide for Trending Cardiovascular Nutritional Controversies in 2026Michael Miller, Monica Aggarwal, Kathleen Allen, et al.
Frontiers in Immunology|February 6, 2024
Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in <i>Helicobacter pylori</i> infectionMargit Anthofer, Markus Windisch, Rosa Haller, et al.
Atherosclerosis|June 27, 2022
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary preventionAbdulhamied Alfaddagh, Karan Kapoor, Zeina A Dardari, et al.
Behavior Genetics|July 23, 2016
A Test-Replicate Approach to Candidate Gene Research on Addiction and Externalizing Disorders: A Collaboration Across Five Longitudinal StudiesDiana R Samek, Jennifer Bailey, Karl G Hill, et al.
Journal of the American Heart Association|February 19, 2025
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized TrialRahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg, et al.
Nature Medicine|June 24, 2023
The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trialDeepak L Bhatt, Harold E Bays, Michael Miller, et al.
Journal of the American Heart Association|March 24, 2020
Barriers, Opportunities, and Challenges in Addressing Disparities in Diet-Related Cardiovascular Disease in the United StatesPenny M Kris-Etherton, Kristina S Petersen, Gladys Velarde, et al.
Journal of Immunological Methods|April 22, 2004
Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assayDavid Opalka, Antonello Pessi, Elisabetta Bianchi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 26, 2021
Using Clinical and Echocardiographic Characteristics to Characterize the Risk of Ischemic Stroke in Patients with COVID-19Connor P Oates, Solomon W Bienstock, Michael Miller, et al.
Nature Medicine|March 4, 2024
Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trialDeepak L Bhatt, Harold E Bays, Michael Miller, et al.
Pageof 66

Showing results (521-530 of 655) with videos related to

Sort By:
Pageof 66
JACC. Advances|February 10, 2026
A Clinician's Guide for Trending Cardiovascular Nutritional Controversies in 2026Michael Miller, Monica Aggarwal, Kathleen Allen, et al.
Frontiers in Immunology|February 6, 2024
Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in <i>Helicobacter pylori</i> infectionMargit Anthofer, Markus Windisch, Rosa Haller, et al.
Atherosclerosis|June 27, 2022
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary preventionAbdulhamied Alfaddagh, Karan Kapoor, Zeina A Dardari, et al.
Behavior Genetics|July 23, 2016
A Test-Replicate Approach to Candidate Gene Research on Addiction and Externalizing Disorders: A Collaboration Across Five Longitudinal StudiesDiana R Samek, Jennifer Bailey, Karl G Hill, et al.
Journal of the American Heart Association|February 19, 2025
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized TrialRahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg, et al.
Nature Medicine|June 24, 2023
The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trialDeepak L Bhatt, Harold E Bays, Michael Miller, et al.
Journal of the American Heart Association|March 24, 2020
Barriers, Opportunities, and Challenges in Addressing Disparities in Diet-Related Cardiovascular Disease in the United StatesPenny M Kris-Etherton, Kristina S Petersen, Gladys Velarde, et al.
Journal of Immunological Methods|April 22, 2004
Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assayDavid Opalka, Antonello Pessi, Elisabetta Bianchi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 26, 2021
Using Clinical and Echocardiographic Characteristics to Characterize the Risk of Ischemic Stroke in Patients with COVID-19Connor P Oates, Solomon W Bienstock, Michael Miller, et al.
Nature Medicine|March 4, 2024
Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trialDeepak L Bhatt, Harold E Bays, Michael Miller, et al.
Pageof 66